Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

How Much Will the First Responder Anthrax Preparedness Act Cost?

by Global Biodefense Staff
January 20, 2016
Anthrax Preparedness

The Congressional Budget Office (CBO) this week released their cost estimate of the S. 1915 First Responder Anthrax Preparedness Act.

Under the bill, anthrax vaccines from the U.S. Strategic National Stockpile would be provided to first responders who volunteer to receive them, and the Department of Homeland Security (DHS) would establish a tracking system for the vaccine and would provide educational outreach for the program.

Vaccines nearing the end of their labeled dates would be prioritized for utilization under the Act.

The bill would direct DHS, in coordination with the U.S. Department of Health and Human Services, to establish a pilot program in at least two states to begin providing the vaccine.

Based on information provided by DHS and HHS, CBO estimates that implementing S. 1915 would cost about $4 million over the 2016-2020 period, assuming appropriation of the necessary amounts.

On June 24, 2015, CBO transmitted a cost estimate for house bill H.R. 1300, the First Responder Anthrax Preparedness Act, as ordered reported by the House Committee on Homeland Security.

Sen. Ayotte, Kelly [R-NH] introduced S. 1915 on August 3, 2015. CBO’s estimate of the budgetary effects of implementing both pieces of legislation is the same.

Tags: AnthraxBioterrorismMobile ResponseVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC